Wedmont Private Capital’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.96M | Buy |
17,334
+1,075
| +7% | +$122K | 0.08% | 147 |
|
|
2025
Q1 | $1.68M | Buy |
16,259
+2,778
| +21% | +$288K | 0.09% | 141 |
|
|
2024
Q4 | $1.21M | Buy |
13,481
+3,931
| +41% | +$353K | 0.06% | 185 |
|
|
2024
Q3 | $806K | Buy |
9,550
+1,998
| +26% | +$169K | 0.05% | 248 |
|
|
2024
Q2 | $528K | Sell |
7,552
-1,916
| -20% | -$134K | 0.03% | 327 |
|
|
2024
Q1 | $662K | Sell |
9,468
-2,008
| -17% | -$140K | 0.05% | 271 |
|
|
2023
Q4 | $964K | Buy |
11,476
+2,333
| +26% | +$196K | 0.08% | 169 |
|
|
2023
Q3 | $686K | Sell |
9,143
-1,600
| -15% | -$120K | 0.07% | 197 |
|
|
2023
Q2 | $829K | Buy |
10,743
+530
| +5% | +$40.9K | 0.09% | 152 |
|
|
2023
Q1 | $844K | Sell |
10,213
-1,339
| -12% | -$111K | 0.11% | 132 |
|
|
2022
Q4 | $1.02M | Buy |
11,552
+1,639
| +17% | +$144K | 0.15% | 101 |
|
|
2022
Q3 | $612K | Buy |
9,913
+3,976
| +67% | +$245K | 0.12% | 132 |
|
|
2022
Q2 | $367K | Buy |
+5,937
| New | +$367K | 0.08% | 190 |
|
|
2022
Q1 | – | Sell |
-3,083
| Closed | -$222K | – | 325 |
|
|
2021
Q4 | $222K | Buy |
+3,083
| New | +$222K | 0.07% | 214 |
|